Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $7.8100 (3.17%) ($7.5900 - $8.1000) on Thu. Nov. 28, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.69% (three month average) | RSI | 51 | Latest Price | $7.8100(3.17%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | TGTX declines -1.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting TGTX price | TGTX will decline at least -1.845% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.845% (StdDev 3.69%) | Hourly BBV | 0 () | Intraday Trend | 1.4% | | | |
|
5 Day Moving Average | $7.67(1.83%) | 10 Day Moving Average | $7.79(0.26%) | 20 Day Moving Average | $7.69(1.56%) | To recent high | -4.4% | To recent low | 53.1% | Market Cap | $N/A | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |